MicroRNA-145 inhibits lung cancer cell metastasis

Molecular Medicine Reports

Volumn 11, Issue 4, 2015, Pages 3108-3114

  Ling, Dong Jin ^a,b   Chen, Zhong Shu ^a,b   Zhang, Yang De ^a   Liao, Qian De ^c   Feng, Jian Xiong ^b   Zhang, Xue Yu ^b   Shi, Tian Sheng ^b  

^a BEIJING HOSPITAL   (China)

^b Jiang Xi Chest Hospital   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Epithelial mesenchymal transition; Lung cancer; Microrna 145; Octamer binding transcription factor 4; Wingless type MMTV integration site family catenin signaling

Indexed keywords

BETA CATENIN; MICRORNA 145; NERVE CELL ADHESION MOLECULE; OCTAMER TRANSCRIPTION FACTOR 4; SHORT HAIRPIN RNA; UVOMORULIN; VIMENTIN; WNT3A PROTEIN; MICRORNA; MIRN145 MICRORNA, HUMAN;

ARTICLE; CELL ADHESION; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CANCER CELL LINE; METASTASIS; WESTERN BLOTTING; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

MOUSE MAMMARY TUMOR VIRUS;

BETA CATENIN; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASM METASTASIS; OCTAMER TRANSCRIPTION FACTOR-3; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WNT3A PROTEIN;

EID: 84921341682     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.3036     Document Type: Article

References (36)

1. Jemal A, Siegel R, Xu J, et al: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Nguyen DX, Bos PD and Massagué J: Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9: 274-284, 2009.
3. Thiery JP: Epithelial-mesenchymal transitions in tumour 4 progression. Nat Rev Cancer 2: 442-454, 2002.
4. Bates RC and Mercurio AM: The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther 4: 365-370, 2005
5. Brabletz T, Hlubek F, Spaderna S, et al: Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs 179: 56-65, 2005.
6. Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428, 2009.
7. Bracken CP, Gregory PA, Khew-Goodall Y and Goodall GJ: The role of microRNAs in metastasis and epithelial-mesenchymal transition. Cell Mol Life Sci 66: 1682-1699, 2009.
8. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
9. Humphreys DT, Westman BJ, Martin DI and Preiss T: MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci USA 102: 16961-16966, 2005.
10. Nicoloso MS, Spizzo R, Shimizu M, et al: MicroRNAs - the micro steering wheel of tumour metastases. Nat Rev Cancer 9: 293-302, 2009.
11. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006.
12. Sempere LF, Christensen M, Silahtaroglu A, et al: Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 67: 11612-11620, 2007.
13. Schepeler T, Reinert JT, Ostenfeld MS, et al: Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68: 6416-6424, 2008.
14. Sachdeva M and Mo YY: MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 70: 378-387, 2010.
15. Wang L, Tang H, Thayanithy V, et al: Gene networks and microRNAs implicated in aggressive prostate cancer. Cancer Res 69: 9490-9497, 2009.
16. Arndt GM, Dossey L, Cullen LM, et al: Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 9: 374, 2009.
17. Yin R, Zhang S, Wu Y, et al: microRNA-145 suppresses lung adenocarcinoma-initiating cell proliferation by targeting Oct4. Oncol Rep 25: 1747-1754, 2011.
18. Thiery JP, Acloque H, Huang RY, et al: Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890, 2009.
19. Lim J and Thiery JP: Epithelial-mesenchymal transitions: insights from development. Development 139: 3471-3486, 2012.
20. Samavarchi-Tehrani P, Golipour A, David L, et al: Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 7: 64-77, 2010.
21. Zhang J and Ma L: MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Rev 31: 653-662, 2012.
22. Scholer H, Ruppert S, Suzuki N, Chowdhury K and Gruss P: New type of POU domain in germ line-specific protein Oct4. Nature 344:435-439, 1990.
23. Nichols J, Zevnik B, Anastassiadis K, et al: Formation of pluripotent stemcells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95: 379-391, 1998.
24. de Jong J and Looijenga LH: Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future. Crit Rev Oncog 12: 171-203, 2006.
25. Kim RJ and Nam JS: Oct4. expression enhances features of cancer stem cells in a mouse model of breast cancer. Lab Anim Res 27: 147-152, 2011.
26. Zhang Y, Zhang X, Wang X, et al: Inhibition of LDH - a by lentivirus-mediated small interfering RNA suppresses intestinal-type gastric cancer tumorigenicity through the downregulation of Oct4. Cancer Lett 321: 45-54, 2012.
27. Chen Z, Xu WR, Qian H, et al: Oct4., a novel marker for human gastric cancer. J Surg Oncol 99: 414-419, 2009
28. Guo Y, Liu S, Wang P, et al: Expression profile of embryonic stem cell-associated genes Oct4., Sox2 and Nanog in human gliomas. Histopathology 59: 763-775, 2011.
29. Iida H, Suzuki M, Goitsuka R and Ueno H: Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2. Int J Oncol 40: 71-79, 2012.
30. Chien AJ, Conrad WH and Moon RT: A Wnt survival guide: from flies to human disease. J Invest Dermatol 129: 1614-1627, 2009
31. Chien AJ and Moon RT: WNTS and WNT receptors as therapeutic tools and targets in human disease processes. Front Biosci 12: 448-457, 2007
32. Moon RT, Kohn AD, De Ferrari GV and Kaykas A: WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 5: 691-701, 2004
33. Fu Y, Zheng S, An N, et al: β-catenin as a potential key target for tumor suppression. Int J Cancer 129: 1541-1551, 2011.
34. Valenta T, Hausmann G and Basler K: The many faces and functions of β-catenin. EMBO J 31: 2714-2736, 2012.
35. Anson M, Crain-Denoyelle AM, Baud V, et al: Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. J Clin Invest 122: 586-599, 2012.
36. Davidson KC, Adams AM, Goodson JM, et al: Wnt/β-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct4. Proc Natl Acad Sci USA 109: 4485-4490, 2012.